As thousands of Xarelto injury lawsuits continue to move forward through the court system, a new report highlights the extent of severe problems and bleeding complications that have been linked to this controversial drug. […]
The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the U.S. who are pursuing a Xarelto lawsuit after experiencing internal bleeding, hemorrhaging or another bleeding injury caused by the drug maker’s failure to adequately warn about the risks associated with use of the anticoagulant.
It is expected that the first Xarelto trial dates in the federal court system may start around this time next year, but time still remains to determine whether you or a loved one may be eligible for compensation as a result of a Xarelto injury. […]
Amid continuing concerns about the risk of uncontrollable bleeding on Xarelto and the lack of an approved reversal agent, Johnson & Johnson indicates that sales of their blockbuster anticoagulant still pushed well past the $1 billion mark last year, helping drive profits even higher for the global pharmaceutical company. […]
A petition has been filed in federal court calling for the consolidation of all lawsuits over bleeding problems with Pradaxa as part of a multidistrict litigation, or MDL, where the cases would be centralized before one judge for coordinated handling during pretrial proceedings. While many people confuse this process with a Pradaxa class action lawsuit, it is different and each injury or wrongful death claim remains an individual case. […]